Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Merle Elloso

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Cytokine|December 19, 2013
The role of interchain disulfide bond in a recombinant human interleukin-17A variantBingyuan Wu, Salman Muzammil, Brian Jones, et al.
Cytokine|August 3, 2010
Expression, refolding and purification of a human interleukin-17A variantBingyuan Wu, Jennifer F Nemeth, Dariusz J Janecki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2019
Combined Blockade of TNF-α and IL-17A Alleviates Progression of Collagen-Induced Arthritis without Causing Serious Infections in MiceFang Shen, Akash H Verma, Amy Volk, et al.
Plos Pathogens|January 28, 2017
IL-27 Limits Type 2 Immunopathology Following Parainfluenza Virus InfectionGaia Muallem, Sagie Wagage, Yan Sun, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 25, 2011
Distinct roles of IL-23 and IL-17 in the development of psoriasis-like lesions in a mouse modelKimiko Nakajima, Takashi Kanda, Mikiro Takaishi, et al.
Frontiers in Immunology|April 30, 2024
IL-23 past, present, and future: a roadmap to advancing IL-23 science and therapyJames G Krueger, Kilian Eyerich, Vijay K Kuchroo, et al.
Immunity|September 18, 2012
The cytokines interleukin 27 and interferon-γ promote distinct Treg cell populations required to limit infection-induced pathologyAisling O'Hara Hall, Daniel P Beiting, Cristina Tato, et al.
Frontiers in Immunology|March 27, 2025
Guselkumab binding to CD64<sup>+</sup> IL-23-producing myeloid cells enhances potency for neutralizing IL-23 signalingKacey L Sachen, Deepa Hammaker, Indra Sarabia, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cytokine|December 19, 2013
The role of interchain disulfide bond in a recombinant human interleukin-17A variantBingyuan Wu, Salman Muzammil, Brian Jones, et al.
Cytokine|August 3, 2010
Expression, refolding and purification of a human interleukin-17A variantBingyuan Wu, Jennifer F Nemeth, Dariusz J Janecki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2019
Combined Blockade of TNF-α and IL-17A Alleviates Progression of Collagen-Induced Arthritis without Causing Serious Infections in MiceFang Shen, Akash H Verma, Amy Volk, et al.
Plos Pathogens|January 28, 2017
IL-27 Limits Type 2 Immunopathology Following Parainfluenza Virus InfectionGaia Muallem, Sagie Wagage, Yan Sun, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 25, 2011
Distinct roles of IL-23 and IL-17 in the development of psoriasis-like lesions in a mouse modelKimiko Nakajima, Takashi Kanda, Mikiro Takaishi, et al.
Frontiers in Immunology|April 30, 2024
IL-23 past, present, and future: a roadmap to advancing IL-23 science and therapyJames G Krueger, Kilian Eyerich, Vijay K Kuchroo, et al.
Immunity|September 18, 2012
The cytokines interleukin 27 and interferon-γ promote distinct Treg cell populations required to limit infection-induced pathologyAisling O'Hara Hall, Daniel P Beiting, Cristina Tato, et al.
Frontiers in Immunology|March 27, 2025
Guselkumab binding to CD64<sup>+</sup> IL-23-producing myeloid cells enhances potency for neutralizing IL-23 signalingKacey L Sachen, Deepa Hammaker, Indra Sarabia, et al.
Pageof 2